InsiderClue
← All stocks

Skye Bioscience, Inc.

SKYE Net selling
CIK 0001516551 #5235 in the set updated 22 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$129.47K
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$129.47K
4 of 4 sales
Net
−$129.47K
−$129.47K against sales at will

By person

6 insiders · 4 transactions
4.4×

Punit Dhillon holds only 4.4 times base salary in stock. $2.71M of shares against $610.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Punit Dhillon last reported holding, valued at $1.91, the price Common Stock was last bought or sold at on the open market here, on 16 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
5AM Partners VII, LLC entity
10% owner
—
$64.73K (2)
−$64.73K
8,979,503
25.35%
$17.15M
−6.7%
Schwab Andrew J.
Director
—
$64.73K (2)
−$64.73K
8,979,503
25.35%
$17.15M
−6.7%
DHILLON PUNIT
Chief Executive Officer
—
—
—
1,419,823
4.01%
$2.71M
+244.0%
Grayson Paul A.
Director
—
—
—
259,701
0.7332%
$496.03K
−25.0%
ARSENAULT KAITLYN
Chief Financial Officer
—
—
—
166,342
0.4696%
$317.71K
−20.7%
Diep Tuan Tu
Chief Operating Officer
—
—
—
82,259
0.2322%
$157.11K
−19.2%

Individual transactions

4
Insider
Date
Role
Action
Shares
Price
Amount
5AM Partners VII, LLC
16 Sep 2026
10% owner
Sell indirect
1,285
$1.91
$2.45K
5AM Partners VII, LLC
16 Sep 2026
10% owner
Sell indirect
32,607
$1.91
$62.28K
Schwab Andrew J.
16 Sep 2026
Director
Sell indirect
1,285
$1.91
$2.45K
Schwab Andrew J.
16 Sep 2026
Director
Sell indirect
32,607
$1.91
$62.28K
Show all 4 transactions →

What was left out

Form 4 filings counted 2
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 4
Transactions with no price 0
Shares from compensation/vesting 0
History held since 28 Mar 2017